| Jean Phillips |
Jean Phillips currently works at Akouos, Inc., as Head-Clinical. |
| Michael J. McKenna |
Michael J. McKenna is the founder of Akouos, Inc. (founded in 2016) where he holds the title of Chief Surgical Officer. He is currently working at Harvard Medical School since 1996 as a Professor. In the past, he worked at Massachusetts Eye & Ear Infirmary, Inc. as Chairman. Dr. McKenna obtained a doctorate degree from Keck School of Medicine of USC. |
| Christian Heath |
Christian Heath currently works at Akouos, Inc., as Head-Operation. |
| Kathleen Reape |
Kathleen Reape currently works at Akouos, Inc., as Chief Development Officer from 2021. Dr. Reape also formerly worked at Taysha Gene Therapies, Inc., as Independent Director from 2020 to 2023, Actavis, Inc., as Senior Vice President-Clinical Development, Allergan Ltd. (Ireland), as Senior Vice President-Clinical Development in 2015, Spark Therapeutics, Inc., as Chief Medical Officer from 2018 to 2020, and Ark Medical Consulting LLC, as President from 2015 to 2016. Dr. Reape received her graduate degree and doctorate degree from the University of Pennsylvania. |
| Tyler Halloran |
Tyler Halloran currently works at Akouos, Inc., as Head-Clinical Development. |
| Ventsi Kichikov |
Ventsi Kichikov currently works at Akouos, Inc., as Head-Information Technology. |
| Aaron Tward |
Aaron Tward is the founder of Affinia Therapeutics, Inc. founded in 2019. He is currently working as an Associate Professor at The University of California, San Francisco since 2022 and as the Chief Scientific Officer at Akouos, Inc. since 2022. Dr. Tward holds a doctorate degree from The University of California, San Francisco. |
| Emmanuel J. Simons |
Emmanuel J. Simons is the founder. He founded Akouos, Inc. in 2016 and currently holds the title of Chief Executive Officer. Dr. Simons has a doctorate degree from Massachusetts Institute of Technology, an MBA from Harvard Business School, and an undergraduate degree from Harvard College. |
| Jennifer A. Wellman |
Jennifer A. Wellman is the founder of Spark Therapeutics, Inc., which was founded in 2013. She held the title of Head-Product Development & Regulatory Strategy at Spark Therapeutics, Inc. Ms. Wellman is currently an Independent Director at Atsena Therapeutics, Inc. since 2021 and Chief Operating Officer at Akouos, Inc. since 2020. In the past, she worked as a Regulatory Director at Raymond G. Perelman Center for Cellular & Molecular from 2005 to 2013 and as an Associate Scientist at Avigen, Inc. from 2000 to 2005. Ms. Wellman completed her undergraduate degree at Queen's University and her graduate degree at the University of New Haven. |
